Solving the Unsolvable: Could Quantum and other Non-traditional Computing hold the key to accelerating drug development?
Join Johnson & Johnson Innovation on December 7th to hear their panel of experts, including Whurley, Founder & CEO, Strangeworks, Denise Ruffner Chief Business Officer, Atom Computing, & Sanjoy Ray, PhD Senior Director, Oncology & Immunology TA R&D IT, Janssen Pharmaceuticals , discuss their views on the application of quantum computing to drug discovery, its …